MediCor eyes US market for silicone breast tech
This article was originally published in Clinica
Executive Summary
As Mentor and Inamed wait to see whether the FDA will lift its 13-year-old ban on silicone gel breast implants and approve their respective products, a third company hoping to capitalise on the market is making plans to start US trials of its silicone implants.